Kestra Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$241K Buy
+2,660
New +$223K ﹤0.01% 466
2025
Q3
– Sell
-170
Closed -$13.3K – 528
2025
Q2
$13.3K Sell
170
-21
-11% -$1.57K ﹤0.01% 540
2025
Q1
$13.8K Buy
191
+124
+185% +$8.88K ﹤0.01% 590
2024
Q4
$4.96K Buy
+67
New +$4.69K ﹤0.01% 909

Other funds holding EW

Kestra Investment Management's EW Position: Q2 2026 in Review

Kestra Investment Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 2,660 shares worth $241K. The stake represents ﹤0.01% of the portfolio and ranks #466 among its holdings. This is a return to the name: Kestra Investment Management previously reported a position in EW as recently as Q2 2025.

Kestra Investment Management first reported a position in EW in Q4 2024 and has held it in 4 quarters since. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Kestra Investment Management held 2,660 shares of Edwards Lifesciences worth $241K as of Q2 2026.
  • Edwards Lifesciences was a new Kestra Investment Management position in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Kestra Investment Management's portfolio in Q2 2026, its #466 holding.
  • Kestra Investment Management first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 4 quarters since.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Kestra Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.